Harnessing the HDAC-histone Deacetylase Enzymes, Inhibitors and How These Can Be Utilised in Tissue Engineering

Overview

Journal Int J Oral Sci

Date 2019 Jun 16

PMID 31201303

Citations 31

Authors

Liam Lawlor

Xuebin B Yang

Affiliations

Soon will be listed here.

Abstract

There are large knowledge gaps regarding how to control stem cells growth and differentiation. The limitations of currently available technologies, such as growth factors and/or gene therapies has led to the search of alternatives. We explore here how a cell's epigenome influences determination of cell type, and potential applications in tissue engineering. A prevalent epigenetic modification is the acetylation of DNA core histone proteins. Acetylation levels heavily influence gene transcription. Histone deacetylase (HDAC) enzymes can remove these acetyl groups, leading to the formation of a condensed and more transcriptionally silenced chromatin. Histone deacetylase inhibitors (HDACis) can inhibit these enzymes, resulting in the increased acetylation of histones, thereby affecting gene expression. There is strong evidence to suggest that HDACis can be utilised in stem cell therapies and tissue engineering, potentially providing novel tools to control stem cell fate. This review introduces the structure/function of HDAC enzymes and their links to different tissue types (specifically bone, cardiac, neural tissues), including the history, current status and future perspectives of using HDACis for stem cell research and tissue engineering, with particular attention paid to how different HDAC isoforms may be integral to this field.

Citing Articles

Short-Chain Fatty Acids: Promising Therapeutic Targets for Respiratory Syncytial Virus Infection.

Liang M, Dong Q, Wu W, Fan J Clin Rev Allergy Immunol. 2025; 68(1):8.

PMID: 39873814 DOI: 10.1007/s12016-024-09018-x.

Mechanisms and cross-talk of regulated cell death and their epigenetic modifications in tumor progression.

He R, Liu Y, Fu W, He X, Liu S, Xiao D Mol Cancer. 2024; 23(1):267.

PMID: 39614268 PMC: 11606237. DOI: 10.1186/s12943-024-02172-y.

Preliminary study of the role of histone deacetylase (HDAC) in steroid-induced avascular necrosis of the femoral head induced by BMSC adipogenic differentiation.

Yu Y, Duan P, Zheng L, Xu J, Pan Z J Orthop Surg Res. 2024; 19(1):645.

PMID: 39396027 PMC: 11481159. DOI: 10.1186/s13018-024-05121-z.

Histone deacetylase inhibition enhances extracellular vesicles from muscle to promote osteogenesis via miR-873-3p.

Chen M, Li Y, Zhang M, Ge S, Feng T, Chen R Signal Transduct Target Ther. 2024; 9(1):256.

PMID: 39343927 PMC: 11439940. DOI: 10.1038/s41392-024-01976-0.

Structure-Based Identification of Novel Histone Deacetylase 4 (HDAC4) Inhibitors.

Agarwal R, Pattarawat P, Duff M, Wang H, Baudry J, Smith J Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065718 PMC: 11279411. DOI: 10.3390/ph17070867.

References

Chen B, Cepko C . HDAC4 regulates neuronal survival in normal and diseased retinas. Science. 2009; 323(5911):256-9. PMC: 3339762. DOI: 10.1126/science.1166226. View

Boyault C, Zhang Y, Fritah S, Caron C, Gilquin B, Kwon S . HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates. Genes Dev. 2007; 21(17):2172-81. PMC: 1950856. DOI: 10.1101/gad.436407. View

Hesse E, Saito H, Kiviranta R, Correa D, Yamana K, Neff L . Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity. J Cell Biol. 2010; 191(7):1271-83. PMC: 3010073. DOI: 10.1083/jcb.201009107. View

Schroeder T, Westendorf J . Histone deacetylase inhibitors promote osteoblast maturation. J Bone Miner Res. 2005; 20(12):2254-63. DOI: 10.1359/JBMR.050813. View

Lee S, Wolfe S . Peripheral nerve injury and repair. J Am Acad Orthop Surg. 2000; 8(4):243-52. DOI: 10.5435/00124635-200007000-00005. View

Naguib M, Bie B, Ting A . Fundamental concepts of epigenetics for consideration in anesthesiology. Curr Opin Anaesthesiol. 2012; 25(4):434-43. DOI: 10.1097/ACO.0b013e3283556211. View

Schroeder T, Nair A, Staggs R, Lamblin A, Westendorf J . Gene profile analysis of osteoblast genes differentially regulated by histone deacetylase inhibitors. BMC Genomics. 2007; 8:362. PMC: 2147034. DOI: 10.1186/1471-2164-8-362. View

Grausenburger R, Bilic I, Boucheron N, Zupkovitz G, El-Housseiny L, Tschismarov R . Conditional deletion of histone deacetylase 1 in T cells leads to enhanced airway inflammation and increased Th2 cytokine production. J Immunol. 2010; 185(6):3489-97. PMC: 3175530. DOI: 10.4049/jimmunol.0903610. View

Sun G, Yu R, Evans R, Shi Y . Orphan nuclear receptor TLX recruits histone deacetylases to repress transcription and regulate neural stem cell proliferation. Proc Natl Acad Sci U S A. 2007; 104(39):15282-7. PMC: 2000559. DOI: 10.1073/pnas.0704089104. View

10.

Ballas N, Battaglioli E, Atouf F, Andres M, Chenoweth J, Anderson M . Regulation of neuronal traits by a novel transcriptional complex. Neuron. 2001; 31(3):353-65. DOI: 10.1016/s0896-6273(01)00371-3. View

11.

Lyssiotis C, Walker J, Wu C, Kondo T, Schultz P, Wu X . Inhibition of histone deacetylase activity induces developmental plasticity in oligodendrocyte precursor cells. Proc Natl Acad Sci U S A. 2007; 104(38):14982-7. PMC: 1986599. DOI: 10.1073/pnas.0707044104. View

12.

Yang X, Tare R, Partridge K, Roach H, Clarke N, Howdle S . Induction of human osteoprogenitor chemotaxis, proliferation, differentiation, and bone formation by osteoblast stimulating factor-1/pleiotrophin: osteoconductive biomimetic scaffolds for tissue engineering. J Bone Miner Res. 2003; 18(1):47-57. DOI: 10.1359/jbmr.2003.18.1.47. View

13.

McKay R . Stem cells in the central nervous system. Science. 1997; 276(5309):66-71. DOI: 10.1126/science.276.5309.66. View

14.

Hsieh J, Nakashima K, Kuwabara T, Mejia E, Gage F . Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc Natl Acad Sci U S A. 2004; 101(47):16659-64. PMC: 527137. DOI: 10.1073/pnas.0407643101. View

15.

Lv L, Sun Y, Han X, Xu C, Tang Y, Dong Q . Valproic acid improves outcome after rodent spinal cord injury: potential roles of histone deacetylase inhibition. Brain Res. 2011; 1396:60-8. DOI: 10.1016/j.brainres.2011.03.040. View

16.

Chang S, McKinsey T, Zhang C, Richardson J, Hill J, Olson E . Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Mol Cell Biol. 2004; 24(19):8467-76. PMC: 516756. DOI: 10.1128/MCB.24.19.8467-8476.2004. View

17.

Jung G, Yoon J, Moon B, Yang D, Kim H, Lee S . Valproic acid induces differentiation and inhibition of proliferation in neural progenitor cells via the beta-catenin-Ras-ERK-p21Cip/WAF1 pathway. BMC Cell Biol. 2008; 9:66. PMC: 2639384. DOI: 10.1186/1471-2121-9-66. View

18.

Alvarez-Buylla A, Temple S . Stem cells in the developing and adult nervous system. J Neurobiol. 1998; 36(2):105-10. View

19.

Granger A, Abdullah I, Huebner F, Stout A, Wang T, Huebner T . Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice. FASEB J. 2008; 22(10):3549-60. PMC: 2537432. DOI: 10.1096/fj.08-108548. View

20.

Lv L, Han X, Sun Y, Wang X, Dong Q . Valproic acid improves locomotion in vivo after SCI and axonal growth of neurons in vitro. Exp Neurol. 2011; 233(2):783-90. PMC: 4172462. DOI: 10.1016/j.expneurol.2011.11.042. View